Stock listing
Dusseldorf:4C9 CVS Group plc Aktie
German listing (Dusseldorf) of CVS Group plc · home listing LSE:CVSG
Follow CVS Group plc into a list and get an email when it puts out news.
Home listing price · LSE:CVSG
1,378.00p GBX (pence) -22.00 (-1.6%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, LSE:CVSG
- Day range
- 1,373.00p – 1,393.00p GBX (pence)Nov 20, 2026
- Volume
- 285,385 sharesNov 20, 2026
- Market cap
- £925.2M GBPAt the close on Nov 20, 2026 · price × 67.14M shares outstanding
- 52-week range
- 1,062.00p – 1,438.00p GBX (pence)Lowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- £4.54M GBPMedian day 298,631 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| LSE:CVSG · Home | 1,378.00p GBX (pence) | -22.00 (-1.6%) | 285,385 | 1,393.00p | 1,393.00p | 1,373.00p | 1,400.00p | Close on Nov 20, 2026 |
| Frankfurt:4C9 | €16.40 EUR | -0.20 (-1.2%) | — | €16.40 | €16.40 | €16.40 | €16.60 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · LSE:CVSG · GBX (pence), adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 1,378.00p | -22.00 | -1.6% | 1,393.00p | 1,393.00p | 1,373.00p | 285,385 | |
| 1,400.00p | +14.00 | +1.0% | 1,390.00p | 1,438.00p | 1,382.00p | 366,412 | |
| 1,386.00p | -24.00 | -1.7% | 1,400.00p | 1,412.00p | 1,386.00p | 274,672 | |
| 1,410.00p | -2.00 | -0.1% | 1,424.00p | 1,432.00p | 1,405.50p | 359,440 | |
| 1,412.00p | +3.00 | +0.2% | 1,425.00p | 1,425.00p | 1,403.97p | 281,259 | |
| 1,409.00p | +6.00 | +0.4% | 1,409.00p | 1,417.00p | 1,397.00p | 249,738 | |
| 1,403.00p | +23.00 | +1.7% | 1,390.00p | 1,408.00p | 1,365.00p | 503,022 | |
| 1,380.00p | +10.00 | +0.7% | 1,370.00p | 1,390.00p | 1,366.00p | 379,378 | |
| 1,370.00p | -2.00 | -0.1% | 1,361.00p | 1,378.00p | 1,354.00p | 307,359 | |
| 1,372.00p | -8.00 | -0.6% | 1,350.00p | 1,380.00p | 1,345.50p | 476,991 | |
| 1,380.00p | -7.65 | -0.6% | 1,360.00p | 1,413.00p | 1,360.00p | 236,330 | |
| 1,387.65p | +20.65 | +1.5% | 1,369.00p | 1,393.78p | 1,353.00p | 822,101 | |
| 1,367.00p | +7.00 | +0.5% | 1,349.00p | 1,384.00p | 1,321.00p | 346,162 | |
| 1,360.00p | +33.00 | +2.5% | 1,330.00p | 1,371.00p | 1,321.00p | 498,859 | |
| 1,327.00p | +12.00 | +0.9% | 1,320.00p | 1,331.00p | 1,314.00p | 526,703 | |
| 1,315.00p | -5.37 | -0.4% | 1,325.00p | 1,340.00p | 1,315.00p | 306,645 | |
| 1,320.37p | +4.37 | +0.3% | 1,310.00p | 1,334.00p | 1,300.00p | 374,329 | |
| 1,316.00p | +12.00 | +0.9% | 1,318.00p | 1,320.00p | 1,289.00p | 154,042 | |
| 1,304.00p | -13.00 | -1.0% | 1,330.00p | 1,330.00p | 1,293.00p | 622,248 | |
| 1,317.00p | +18.00 | +1.4% | 1,316.00p | 1,322.00p | 1,294.00p | 213,065 | |
| 1,299.00p | -4.00 | -0.3% | 1,287.00p | 1,312.00p | 1,286.00p | 231,490 | |
| 1,303.00p | -20.00 | -1.5% | 1,330.00p | 1,330.00p | 1,302.00p | 540,351 | |
| 1,323.00p | +34.00 | +2.6% | 1,280.00p | 1,326.00p | 1,280.00p | 590,263 | |
| 1,289.00p | +4.00 | +0.3% | 1,275.00p | 1,289.00p | 1,270.00p | 280,303 | |
| 1,285.00p | +39.00 | +3.1% | 1,252.00p | 1,285.00p | 1,244.00p | 329,732 | |
| 1,246.00p | +16.00 | +1.3% | 1,227.00p | 1,246.00p | 1,213.00p | 298,631 | |
| 1,230.00p | +21.00 | +1.7% | 1,209.00p | 1,239.00p | 1,209.00p | 399,139 | |
| 1,209.00p | +26.00 | +2.2% | 1,189.00p | 1,211.00p | 1,189.00p | 251,332 | |
| 1,183.00p | +10.00 | +0.9% | 1,173.00p | 1,183.00p | 1,168.00p | 183,015 | |
| 1,173.00p | +28.00 | +2.4% | 1,180.00p | 1,180.00p | 1,161.00p | 144,324 | |
| 1,145.00p | -18.00 | -1.5% | 1,150.00p | 1,155.00p | 1,137.00p | 290,782 | |
| 1,163.00p | -7.00 | -0.6% | 1,150.00p | 1,190.00p | 1,150.00p | 284,167 | |
| 1,170.00p | +20.00 | +1.7% | 1,163.00p | 1,191.00p | 1,159.00p | 343,993 | |
| 1,150.00p | +10.00 | +0.9% | 1,150.00p | 1,166.00p | 1,137.00p | 452,831 | |
| 1,140.00p | -20.00 | -1.7% | 1,160.00p | 1,169.00p | 1,136.00p | 483,336 | |
| 1,160.00p | -59.00 | -4.8% | 1,214.00p | 1,214.00p | 1,147.00p | 338,780 | |
| 1,219.00p | -21.00 | -1.7% | 1,280.00p | 1,280.00p | 1,212.00p | 1,205,027 | |
| 1,240.00p | -13.00 | -1.0% | 1,240.00p | 1,264.00p | 1,240.00p | 838,799 | |
| 1,253.00p | +45.00 | +3.7% | 1,232.00p | 1,267.00p | 1,227.00p | 880,192 | |
| 1,208.00p | -13.00 | -1.1% | 1,250.00p | 1,288.00p | 1,208.00p | 460,402 | |
| 1,221.00p | -81.00 | -6.2% | 1,299.00p | 1,299.00p | 1,213.00p | 712,167 | |
| 1,302.00p | -11.00 | -0.8% | 1,300.00p | 1,323.00p | 1,296.00p | 217,233 | |
| 1,313.00p | +7.00 | +0.5% | 1,300.00p | 1,319.00p | 1,289.00p | 326,284 | |
| 1,306.00p | +4.00 | +0.3% | 1,312.00p | 1,312.00p | 1,277.00p | 343,046 | |
| 1,302.00p | -16.00 | -1.2% | 1,318.00p | 1,330.00p | 1,301.00p | 365,109 | |
| 1,318.00p | +27.00 | +2.1% | 1,253.00p | 1,325.00p | 1,253.00p | 194,635 | |
| 1,291.00p | +3.00 | +0.2% | 1,290.00p | 1,299.00p | 1,275.00p | 215,844 | |
| 1,288.00p | -9.00 | -0.7% | 1,292.00p | 1,297.00p | 1,273.00p | 406,074 | |
| 1,297.00p | +2.00 | +0.2% | 1,280.00p | 1,310.00p | 1,280.00p | 345,750 | |
| 1,295.00p | +5.00 | +0.4% | 1,280.00p | 1,301.00p | 1,280.00p | 156,296 | |
| 1,290.00p | +9.00 | +0.7% | 1,260.00p | 1,308.00p | 1,260.00p | 226,154 | |
| 1,281.00p | -22.00 | -1.7% | 1,310.00p | 1,310.00p | 1,268.00p | 190,132 | |
| 1,303.00p | -25.00 | -1.9% | 1,323.00p | 1,327.00p | 1,294.00p | 175,825 | |
| 1,328.00p | +12.00 | +0.9% | 1,312.00p | 1,343.00p | 1,312.00p | 239,331 | |
| 1,316.00p | 0.00 | 0.0% | 1,324.00p | 1,324.00p | 1,303.00p | 206,038 | |
| 1,316.00p | +27.00 | +2.1% | 1,324.00p | 1,324.00p | 1,285.00p | 184,461 | |
| 1,289.00p | -8.00 | -0.6% | 1,279.00p | 1,298.00p | 1,273.00p | 151,999 | |
| 1,297.00p | -25.00 | -1.9% | 1,305.00p | 1,318.00p | 1,287.00p | 939,375 | |
| 1,322.00p | +24.00 | +1.8% | 1,308.00p | 1,322.00p | 1,293.00p | 213,654 | |
| 1,298.00p | -1.00 | -0.1% | 1,297.00p | 1,301.00p | 1,289.00p | 62,590 | |
| 1,299.00p | +3.00 | +0.2% | 1,294.00p | 1,303.00p | 1,293.00p | 79,133 | |
| 1,296.00p | +4.00 | +0.3% | 1,279.00p | 1,304.00p | 1,279.00p | 100,117 | |
| 1,292.00p | -4.00 | -0.3% | 1,293.00p | 1,305.00p | 1,283.00p | 154,494 | |
| 1,296.00p | -13.00 | -1.0% | 1,310.00p | 1,310.00p | 1,291.00p | 146,425 | |
| 1,309.00p | +1.00 | +0.1% | 1,308.00p | 1,315.00p | 1,293.00p | 103,158 |
- Ticker
- Dusseldorf:4C9
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Nov 18, 2026
Standard form for notification of major holdings
Latest earnings call · Sep 24, 2026
CVS Group (LSE:CVSG) Q4 2026 Earnings Call
Replay and transcript
Latest deck · Sep 24, 2026
FY 2026 Earnings Presentation
Earnings · 35 slides
Latest news
Standard form for notification of major holdings
Nov 18, 2026
Closed 1,378.00p (-1.6%) on Nov 20, 2026
Transaction in Own Shares
Nov 16, 2026
Closed 1,410.00p (-0.1%) on Nov 16, 2026
Total Voting Rights
Oct 30, 2026
Closed 1,327.00p (+0.9%) on Oct 30, 2026
Posting of Annual Report and Notice of AGM
Oct 23, 2026
Closed 1,317.00p (+1.4%) on Oct 23, 2026
TVR & Confirmation of Dividend Dates
Sep 30, 2026
Closed 1,219.00p (-1.7%) on Sep 30, 2026
Final results for the year ended 30 June 2026
Sep 24, 2026
Closed 1,221.00p (-6.2%) on Sep 24, 2026
Transaction in Own Shares and Total Voting Rights
Sep 1, 2026
Closed 1,297.00p (-1.9%) on Sep 1, 2026
Updated: Transaction in Own Shares
Jun 8, 2026
Closed 1,232.00p (-0.8%) on Jun 8, 2026
Changes to NEDs' Responsibilities
May 26, 2026
Closed 1,269.00p (+5.8%) on May 26, 2026
Refinancing, Launch of SBB and Acquisition
May 26, 2026
Closed 1,269.00p (+5.8%) on May 26, 2026
CVS Group plc on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 50 in the last 12 months · 204 in all · newest Nov 18, 2026 · oldest 2007
- Calls
- 11 calls with a replay · 11 with a transcript · latest Sep 24, 2026
- Decks
- 9 decks · latest Sep 24, 2026
Where CVS Group plc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| LSE:CVSG · Home listing | LSE | United Kingdom | GBX |
| Turquoise:CVSGL | Turquoise | United Kingdom | GBX |
| LS Exchange:A0M5AJ | LS Exchange | Germany | EUR |
| Lang & Schwarz:A0M5AJ | Lang & Schwarz | Germany | EUR |
| OTC:CVSGF | OTC | United States | USD |
| gettex:4C9 | gettex | Germany | EUR |
| AQUIS:CVSG.GB | AQUIS | United Kingdom | GBX |
| Aquis:CVSGL | Aquis | United Kingdom | GBX |
| Dusseldorf:4C9 · This page | Dusseldorf | Germany | EUR |
| Frankfurt:4C9 | Frankfurt | Germany | EUR |
| Stuttgart:4C9 | Stuttgart | Germany | EUR |
Valuation
P/E 5.3× against a median of 27.2×: 2nd lowest of 11 Health care services companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- £1.23B GBP
- P/E
- 5.3×
- EV/sales
- 0.2×
- EV/EBITDA
- 2.3×
- Price/book
- 3.2×
- Gross margin
- 44.3%
- Operating margin
- 6.7%
- Net margin
- 2.4%
- Debt to equity
- 1.1×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| CVS Group plc · LSE:CVSG | US$1.21B | US$1.61B | 5.3× | 0.2× | 2.3× | 3.2× | 2.4% | 1.1× | n/a |
| Clariane SE · EURONEXT:CLARI | US$1.28B | US$8.88B | 731× | 1.5× | 8.0× | 0.3× | 0.0% | 2.3× | n/a |
| Metropolis Healthcare Ltd. · NSE:METROPOLIS | US$1.27B | US$1.26B | 52.4× | 6.6× | 26.0× | 7.2× | 12.6% | 0.2× | n/a |
| Diagnostyka S.A. · GPW:DIA | US$1.26B | US$1.43B | 20.0× | 2.3× | 9.6× | 10.0× | 9.9% | 1.4× | n/a |
| InnovAge Holding Corp. · NASDAQ:INNV | US$1.25B | US$1.13B | 139× | 1.1× | 31.3× | 4.9× | 0.9% | 0.2× | 0.72 |
| Netcare Limited · JSE:NTC | US$1.24B | US$1.90B | 12.5× | 1.3× | 6.8× | 2.0× | 6.6% | 1.3× | n/a |
| The Pennant Group, Inc. · NASDAQ:PNTG | US$1.22B | US$1.39B | 33.9× | 1.2× | 17.4× | 2.9× | 3.0% | 0.5× | 0.44 |
| C.Q. Pharmaceutical Holding Co., Ltd. Class A · SZSE:000950 | US$1.21B | US$804.4M | 24.9× | 0.1× | n/a | 0.7× | 0.4% | 0.1× | n/a |
| Uniphar PLC · EURONEXT:UPR | US$1.19B | US$1.67B | 21.2× | 0.5× | 12.0× | 2.5× | 1.7% | 1.2× | n/a |
| Selcuk Ecza Deposu Ticaret ve Sanayi A.S. · BIST:SELEC | US$1.19B | US$951.9M | 29.5× | 0.3× | 4.8× | 1.6× | 1.0% | 0.0× | n/a |
| Genertec Universal Medical Group Company Limited · HKEX:2666 | US$1.15B | US$8.39B | 3.5× | 3.9× | 4.2× | 0.4× | 15.2% | 2.6× | n/a |
| Median of the others | US$1.23B | US$1.41B | 27.2× | 1.2× | 9.6× | 2.3× | 2.4% | 0.8× | 0.58 |
Forecasts
Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 1590.42 GBX · Analysts' mean
- EPS, year to Jun 2027
- 0.96 · 12 analysts
- Revenue, year to Jun 2027
- 751M · 10 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Scott Morrison | Group Legal Counsel and Company Secretary |
| Charlotte Page | Head of Investor Relations |
Board
| Director | Role |
|---|---|
| Laura Hagan | Director |
Events
- Next results
- Feb 25, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| CVS Group (LSE:CVSG) Q4 2026 Earnings Call | Thu, Sep 24, 2026 · 4:30 AM ET | Replay |
| CVS Group (LSE:CVSG) Q4 2025 Earnings Call | Tue, Oct 07, 2025 · 8:00 AM ET | Replay |
| CVS Group (LSE:CVSG) Q2 2025 Earnings Call | Thu, Feb 27, 2025 · 2:00 AM ET | Replay |
| CVS Group (LSE:CVSG) Q4 2024 Earnings Call | Thu, Sep 26, 2024 · 2:00 AM ET | Replay |
| CVS Group (LSE:CVSG) Q2 2024 Earnings Call | Thu, Feb 29, 2024 · 4:00 AM ET | Replay |
| CVS Group (LSE:CVSG) Q4 2023 Earnings Call | Thu, Sep 21, 2023 · 4:00 AM ET | Replay |
| CVS Group (LSE:CVSG) Q2 2023 Earnings Call | Fri, Feb 24, 2023 · 4:00 AM ET | Replay |
| CVS Group (LSE:CVSG) Q4 2022 Earnings Call | Wed, Sep 21, 2022 · 3:30 AM ET | Replay |
| CVS Group (LSE:CVSG) Q2 2022 Earnings Call | Thu, Mar 24, 2022 · 4:00 AM ET | Replay |
| CVS Group (LSE:CVSG) Q4 2021 Earnings Call | Tue, Sep 21, 2021 · 4:00 AM ET | Replay |
All 11 calls
| Call | When | Status |
|---|---|---|
| CVS Group (LSE:CVSG) Q2 2021 Earnings Call | Thu, Mar 25, 2021 · 4:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2025 | Oct 7, 2025 · After close | +2.6% |
| Q2 2025 | Feb 27, 2025 | −3.6% |
| Q2 2023 | Feb 24, 2023 · Before open | −0.7% |
| Q4 2022 | Sep 22, 2022 · Before open | −0.4% |
| Q2 2022 | Mar 24, 2022 · Before open | +4.0% |
| Q4 2021 | Sep 22, 2021 | +8.6% |
| Q2 2021 | Mar 25, 2021 | −0.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY 2026 Earnings Presentation | Earnings | 35 slides | Sep 24, 2026 |
| FY2024 Earnings Presentation | Earnings | 28 slides | Sep 26, 2024 |
| FY2014 Earnings Presentation | Earnings | 36 slides | September 2014 |
| FY2013 Earnings Presentation | Earnings | 42 slides | September 2013 |
| FY2012 Earnings Presentation | Earnings | 28 slides | September 2012 |
| H1 2012 Earnings Presentation | Earnings | 28 slides | March 2012 |
| FY2011 Earnings Presentation | Earnings | 26 slides | September 2011 |
| FY2010 Earnings Presentation | Earnings | 24 slides | October 2010 |
| FY2009 Earnings Presentation | Earnings | 18 slides | September 2009 |
Financials
Annual, in GBP
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.13B | 6.73B | 647.3M | 588.9M | 554.2M | 510.1M | 427.8M | 406.5M | 327.3M | 271.8M |
| Cost of revenue | 3.97B | 3.88B | 369.4M | 346.0M | 315.1M | 288.2M | 257.7M | 237.6M | 175.7M | 147.3M |
| Gross profit | 3.16B | 2.86B | 277.9M | 262.3M | 239.1M | 221.9M | 170.1M | 168.9M | 151.6M | 124.5M |
| Selling, general and administrative | 268.0M | 227.1M | 200.0M | 196.3M | 181.8M | 151.6M | 153.3M | 133.9M | 107.3M | |
| Operating income | 476.0M | 498.0M | 50.8M | 74.5M | 42.8M | 40.1M | 18.5M | 15.6M | 17.7M | 17.2M |
| Depreciation and amortization | 64.7M | 64.5M | 58.5M | 50.4M | 47.6M | 48.1M | 46.4M | 31.4M | 26.4M | 21.9M |
| EBITDA | 540.7M | 562.5M | 109.3M | 124.9M | 90.4M | 88.2M | 64.9M | 47.0M | 44.1M | 39.1M |
| Interest expense | 156.0M | 172.0M | 12.6M | 7.70M | 6.80M | 7.00M | 8.60M | 3.90M | 3.60M | 2.70M |
| Income before tax | 320.0M | 326.0M | 38.2M | 60.7M | 36.0M | 33.1M | 9.90M | 11.7M | 14.1M | 14.5M |
| Income tax | 142.0M | 135.0M | 11.8M | 12.6M | 10.3M | 13.8M | 4.20M | 3.50M | 3.40M | 3.00M |
| Net income | 173.0M | 528.0M | 6.20M | 41.9M | 25.7M | 19.3M | 5.70M | 8.20M | 10.7M | 11.5M |
| Earnings per share, basic | 2.44 | 2.63 | 0.09 | 0.58 | 0.36 | 0.27 | 0.08 | 0.12 | 0.16 | 0.18 |
| Earnings per share, diluted | 2.43 | 2.62 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 184.0M | 161.0M | 16.5M | 21.5M | 49.0M | 33.7M | 21.5M | 12.5M | 15.0M | 6.80M |
| Short-term investments | -2.30M | 1.20M | -100.0K | -200.0K | -100.0K | |||||
| Receivables | 100.2M | 77.4M | 55.5M | 48.8M | 42.1M | 39.6M | 35.4M | 42.3M | 28.3M | 21.8M |
| Inventory | 297.0M | 285.0M | 31.8M | 28.4M | 26.2M | 19.5M | 18.7M | 17.0M | 13.5M | 12.5M |
| Current assets | 1.48B | 1.35B | 128.6M | 111.8M | 127.9M | 101.4M | 83.6M | 81.1M | 66.7M | 50.2M |
| Property, plant and equipment | 1.35B | 1.24B | 204.4M | 171.4M | 154.6M | 149.7M | 51.4M | 47.9M | 43.0M | |
| Goodwill | 266.8M | 231.7M | 221.7M | 162.5M | 120.6M | 113.9M | 100.2M | 95.3M | 68.4M | 46.8M |
| Total assets | 7.68B | 6.96B | 690.0M | 572.3M | 518.2M | 484.5M | 464.3M | 377.4M | 319.0M | 262.7M |
| Accounts payable | 1.06B | 1.05B | 50.1M | 41.5M | 86.6M | 40.3M | 39.4M | 42.2M | 31.3M | 24.5M |
| Current liabilities | 1.26B | 1.23B | 118.1M | 105.1M | 101.4M | 98.5M | 102.0M | 78.9M | 58.0M | 54.4M |
| Long-term debt | 214.1M | 181.3M | 92.2M | 84.3M | 83.9M | 83.5M | 114.2M | 83.5M | 103.5M | |
| Total debt | 2.14B | 1.45B | 287.8M | 199.1M | 188.8M | 182.7M | 182.2M | 114.5M | 84.0M | 106.8M |
| Total liabilities | 4.72B | 3.94B | 429.5M | 315.3M | 300.8M | 293.4M | 297.7M | 214.3M | 161.3M | 174.7M |
| Shareholders' equity | 2.90B | 3.00B | 260.4M | 257.0M | 217.4M | 191.1M | 166.6M | 163.1M | 157.7M | 88.0M |
| Shares outstanding | 71.0M | 71.7M | 71.7M | 71.7M | 71.6M | 71.2M | 70.8M | 70.6M | 66.7M | 63.1M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 713.0M | 821.0M | 67.8M | 84.5M | 75.5M | 60.2M | 77.6M | 41.4M | 37.4M | 29.7M |
| Capital spending | -285.0M | -264.0M | -43.1M | -45.7M | -24.5M | -16.6M | -12.4M | -12.9M | -10.7M | -13.8M |
| Free cash flow | 428.0M | 557.0M | 24.7M | 38.8M | 51.0M | 43.6M | 65.2M | 28.5M | 26.7M | 15.9M |
| Cash from investing | -794.0M | -227.0M | -140.5M | -99.9M | -45.1M | -35.4M | -19.6M | -69.5M | -61.0M | -60.7M |
| Cash from financing | 106.0M | -592.0M | 68.3M | -12.1M | -15.1M | -12.6M | -49.0M | 25.6M | 31.8M | 31.1M |
| Dividends paid | -63.0M | -59.0M | -5.40M | -5.00M | -4.60M | -3.90M | -3.90M | -3.50M | -2.90M | -2.10M |
| Share buybacks | -31.7M | -900.0K | -1.20M | 4.60M | 3.90M | 65.2M | -28.5M | 61.0M | -2.10M | |
| Change in cash | 23.0M | -4.00M | -5.00M | -27.5M | 15.3M | 12.2M | 9.00M | -2.50M | 8.20M | 100.0K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Transaction in Own Shares | Nov 16, 2026 | Treasury share status | London Stock Exchange |
| Transaction in Own Shares | Nov 9, 2026 | Treasury share status | London Stock Exchange |
| Transaction in Own Shares | Nov 2, 2026 | Treasury share status | London Stock Exchange |
| Transaction in Own Shares | Oct 26, 2026 | Treasury share status | London Stock Exchange |
| Transaction in Own Shares | Oct 19, 2026 | Treasury share status | London Stock Exchange |
| Transaction in Own Shares | Oct 12, 2026 | Treasury share status | London Stock Exchange |
| Transaction in Own Shares | Oct 5, 2026 | Treasury share status | London Stock Exchange |
| Transaction in Own Shares and Total Voting Rights | Sep 1, 2026 | Treasury share status | London Stock Exchange |
| Updated: Transaction in Own Shares | Jun 8, 2026 | Treasury share status | London Stock Exchange |
Cap table
Built by 6ix from CVS Group plc’s releases
- Common shares
- 67,138,342
- Fully diluted
- 67,138,342
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 67,138,342 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 67,138,342 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Charlotte Page | Head of Investor Relations · Since at least Sep 1, 2026 |
| Christopher Marsh | Director · Until Dec 10, 2010 · Past |
| Laura Hagan | Director · Since at least Apr 21, 2026 |
| Richard Fairman | CEO · Nov 26, 2024 – Nov 5, 2026 · Past |
| Scott Morrison | Group Legal Counsel and Company Secretary · Since at least May 26, 2026 |
Log in to ask 6ix AI your own questions about CVS Group plc.